Qiufang Jing

458 total citations
23 papers, 374 citations indexed

About

Qiufang Jing is a scholar working on Pharmaceutical Science, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Qiufang Jing has authored 23 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 8 papers in Materials Chemistry. Recurrent topics in Qiufang Jing's work include Drug Solubulity and Delivery Systems (16 papers), Crystallization and Solubility Studies (8 papers) and Advanced Drug Delivery Systems (7 papers). Qiufang Jing is often cited by papers focused on Drug Solubulity and Delivery Systems (16 papers), Crystallization and Solubility Studies (8 papers) and Advanced Drug Delivery Systems (7 papers). Qiufang Jing collaborates with scholars based in China, Macao and United States. Qiufang Jing's co-authors include Fuzheng Ren, Hui Xiong, Defang Ouyang, Yongjia Shen, Zhuyifan Ye, Yilong Yang, Hao Pan, Tianhe Huang, Run Han and Guo‐Bin Ren and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and RSC Advances.

In The Last Decade

Qiufang Jing

22 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiufang Jing China 10 164 98 93 58 50 23 374
Qianqian Zhao China 13 182 1.1× 104 1.1× 86 0.9× 67 1.2× 44 0.9× 25 440
Hans H. Lindén Sweden 6 266 1.6× 101 1.0× 155 1.7× 70 1.2× 53 1.1× 9 502
Gergő Dargó Hungary 9 114 0.7× 96 1.0× 62 0.7× 65 1.1× 40 0.8× 23 324
Niklas J. Koehl Ireland 12 271 1.7× 88 0.9× 109 1.2× 81 1.4× 30 0.6× 19 461
Maria Vertzoni Greece 9 272 1.7× 73 0.7× 81 0.9× 72 1.2× 29 0.6× 11 404
Jiawei Han China 14 228 1.4× 92 0.9× 104 1.1× 37 0.6× 40 0.8× 28 495
Neha Dand India 7 225 1.4× 110 1.1× 65 0.7× 33 0.6× 48 1.0× 16 453
Lincy Joseph India 8 130 0.8× 53 0.5× 70 0.8× 37 0.6× 25 0.5× 51 454
Larissa Sakis Bernardi Brazil 13 183 1.1× 65 0.7× 128 1.4× 93 1.6× 33 0.7× 38 433
Arun Rasheed India 12 281 1.7× 146 1.5× 67 0.7× 66 1.1× 35 0.7× 38 653

Countries citing papers authored by Qiufang Jing

Since Specialization
Citations

This map shows the geographic impact of Qiufang Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiufang Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiufang Jing more than expected).

Fields of papers citing papers by Qiufang Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiufang Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiufang Jing. The network helps show where Qiufang Jing may publish in the future.

Co-authorship network of co-authors of Qiufang Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Qiufang Jing. A scholar is included among the top collaborators of Qiufang Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiufang Jing. Qiufang Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jing, Qiufang, Xiaoyan Guo, Xinyu Chen, et al.. (2024). Module-combinatorial design and screening of multifunctional polymers based on polyaspartic acid for DNA delivery. International Journal of Pharmaceutics. 661. 124350–124350.
2.
Guo, Ziyan, et al.. (2023). Corosolic acid-modified lipid nanoparticles as delivery carriers for DNA vaccines against avian influenza. International Journal of Pharmaceutics. 638. 122914–122914. 5 indexed citations
3.
Jing, Qiufang, Xuanyu Wang, Wenyun Zheng, et al.. (2023). Immuno-Enhancing Effect of Ginsenoside Rh2 Liposomes on Foot-and-Mouth Disease Vaccine. Molecular Pharmaceutics. 21(1). 183–193. 5 indexed citations
4.
Jia, Shuyu, et al.. (2022). Stabilizing Effect of Soluplus on Erlotinib Metastable Crystal Form in Microparticles and Amorphous Solid Dispersions. Polymers. 14(6). 1241–1241. 17 indexed citations
5.
Li, Qiang, Qianqian Zhao, Qiufang Jing, et al.. (2019). Investigating molecular interactions of high-loaded glipizide-HPMCAS microparticles by integrated experimental and modeling techniques. European Journal of Pharmaceutical Sciences. 131. 127–135. 16 indexed citations
6.
Han, Run, Hui Xiong, Zhuyifan Ye, et al.. (2019). Predicting physical stability of solid dispersions by machine learning techniques. Journal of Controlled Release. 311-312. 16–25. 120 indexed citations
7.
Fu, Jinping, Lin Cui, Hui Xiong, et al.. (2018). Screen for Inhibitors of Crystal Growth to Identify Desirable Carriers for Amorphous Solid Dispersions Containing Felodipine. AAPS PharmSciTech. 19(3). 1231–1242. 6 indexed citations
8.
Ren, Fuzheng, et al.. (2018). Antisolvent Recrystallization Strategy to Screen Appropriate Carriers to Stabilize Filgotinib Amorphous Solid Dispersions. Journal of Pharmaceutical Sciences. 107(6). 1624–1632. 5 indexed citations
9.
Chen, Ning, Peiwen Di, Wenjun Jiang, et al.. (2018). Modified rivaroxaban microparticles for solid state properties improvement based on drug-protein/polymer supramolecular interactions. Powder Technology. 344. 819–829. 14 indexed citations
10.
Liu, Yan, Yaru Zhou, Qiang Li, et al.. (2018). Exploring the effect of PVP on the spherical agglomeration process and micromeritic properties of ascorbic acid. Powder Technology. 342. 929–937. 9 indexed citations
11.
Di, Peiwen, Jinping Fu, Hui Xiong, et al.. (2017). Improving the physicochemical properties of bicalutamide by complex formation with bovine serum albumin. European Journal of Pharmaceutical Sciences. 106. 381–392. 12 indexed citations
12.
Ren, Fuzheng, Jinping Fu, Hui Xiong, et al.. (2017). Complexes of Felodipine Nanoparticles With Zein Prepared Using a Dual Shift Technique. Journal of Pharmaceutical Sciences. 107(1). 239–249. 11 indexed citations
14.
Ren, Fuzheng, Yaru Zhou, Yan Liu, et al.. (2016). A mixed solvent system for preparation of spherically agglomerated crystals of ascorbic acid. Pharmaceutical Development and Technology. 22(6). 818–826. 9 indexed citations
15.
Ren, Fuzheng, et al.. (2016). Characterization of ibuprofen microparticle and improvement of the dissolution. Pharmaceutical Development and Technology. 22(1). 63–68. 6 indexed citations
16.
Ren, Fuzheng, et al.. (2013). New self-nanoemulsifying drug delivery system (SNEDDS) with amphiphilic diblock copolymer methoxy poly (ethylene glycol)-block-poly (ϵ-caprolactone). Pharmaceutical Development and Technology. 18(3). 745–751. 2 indexed citations
17.
Jing, Qiufang, et al.. (2006). Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC. Journal of Pharmaceutical and Biomedical Analysis. 41(3). 1065–1069. 11 indexed citations
18.
Ren, Fuzheng, et al.. (2006). Quantitative determination of puerarin in dog plasma by HPLC and study on the relative bioavailability of sustained release tablets. Journal of Pharmaceutical and Biomedical Analysis. 41(2). 549–553. 40 indexed citations
19.
Jing, Qiufang, et al.. (2006). HPLC determination of anethole trithione and its application to pharmacokinetics in rabbits. Journal of Pharmaceutical and Biomedical Analysis. 42(5). 613–617. 18 indexed citations
20.
Ren, Fuzheng, et al.. (2006). Characteristics of Bicalutamide Solid Dispersions and Improvement of the Dissolution. Drug Development and Industrial Pharmacy. 32(8). 967–972. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026